As we enter flu season, a San Diego-based firm has acquired emergency FDA clearance for a check that may display for the flu, coronavirus and different viruses on one affected person pattern.
It’s meant to maintain hospitals from being overwhelmed as the continuing COVID-19 pandemic overlaps with flu season. The 2 illnesses current lots of the similar signs.
Carlsbad-based GenMark Diagnostics has been given Emergency Use authorization for it’s ePlex® Respiratory Pathogen Panel 2 (RP2), a fast outcome multiplex molecular diagnostic check.
CEO Scott Mendel informed NBC 7 the check can display a critically unwell affected person for a number of viruses together with the coronavirus and outcomes take lower than two hours.
It may assist well being care suppliers on the entrance strains, too.
“One among their nurses introduced a fever and so they have been uncertain what she had,” stated Mendel, recounting an instance of how the check helped a hospital make better-informed selections. “Solely did they know that she didn’t have COVID-19, that they had much more confidence as a result of they have been in a position to establish what she did have, which was simply the frequent chilly.”
Hospitals like Rady Youngsters’s and Scripps have been utilizing an easier model of the check for years, however will now pivot to the expanded model.
Mendel informed NBC 7 the check has been in the marketplace for small scale use since July. The FDA approval permits for corporations to shorten the everyday 6 to 12-month course of to get it commercialized and distributed to extra locations across the nation.
The check will solely be out there to hospitals and well being care suppliers to be used on sufferers.